Molecular Biomarker Testing Guideline Development & Implementation
Develop and promulgate evidence-based guidelines and practice implementation strategies for molecular biomarker testing in oncology to promote appropriate and equitable access to high-quality guideline-concordant patient care.
Key Activities
Multi-society guideline development (with ASCP, CAP, ASCO, NSGC, ACCC, SITC, ADLM, ACMG, ISLB, LUNGevity, Fight Colorectal Cancer and others) and stakeholder engagement for lung, colorectal, breast, and other cancers.